Skip to main content
Log in

Implementing PGD/PGD-A in IVF clinics: considerations for the best laboratory approach and management

  • Review
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

For an IVF clinic that wishes to implement preimplantation genetic diagnosis for monogenic diseases (PGD) and for aneuploidy testing (PGD-A), a global improvement is required through all the steps of an IVF treatment and patient care. At present, CCS (Comprehensive Chromosome Screening)-based trophectoderm (TE) biopsy has been demonstrated as a safe, accurate and reproducible approach to conduct PGD-A and possibly also PGD from the same biopsy. Key challenges in PGD/PGD-A implementation cover genetic and reproductive counselling, selection of the most efficient approach for blastocyst biopsy as well as of the best performing molecular technique to conduct CCS and monogenic disease analysis. Three different approaches for TE biopsy can be compared. However, among them, the application of TE biopsy approaches, entailing the zona opening when the expanded blastocyst stage is reached, represent the only biopsy methods suited with a totally undisturbed embryo culture strategy (time lapse-based incubation in a single media). Moreover, contemporary CCS technologies show a different spectrum of capabilities and limits that potentially impact the clinical outcomes, the management and the applicability of the PGD-A itself. In general, CCS approaches that avoid the use of whole genome amplification (WGA) can provide higher reliability of results with lower costs and turnaround time of analysis. The future perspectives are focused on the scrupulous and rigorous clinical validations of novel CCS methods based on targeted approaches that avoid the use of WGA, such as targeted next-generation sequencing technology, to further improve the throughput of analysis and the overall cost-effectiveness of PGD/PGD-A.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990;344(6268):768–70.

    Article  CAS  PubMed  Google Scholar 

  2. Lee E, Illingworth P, Wilton L, Chambers GM. The clinical effectiveness of preimplantation genetic diagnosis for aneuploidy in all 24 chromosomes (PGD-A): systematic review. Hum Reprod. 2015;30(2):473–83.

    Article  PubMed  Google Scholar 

  3. Dahdouh EM, Balayla J, García-Velasco JA. Comprehensive chromosome screening improves embryo selection: a meta-analysis. Fertil Steril. 2015;104(6):1503–12.

    Article  PubMed  Google Scholar 

  4. Dahdouh EM, Balayla J, Audibert F, Genetics Committee, Wilson RD, Audibert F, et al. Technical update: preimplantation genetic diagnosis and screening. J Obstet Gynaecol Can. 2015;37(5):451–63.

    Article  PubMed  Google Scholar 

  5. Chen M, Wei S, Hu J, Quan S. Can comprehensive chromosome screening technology improve IVF/ICSI outcomes? A Meta-Analysis. PLoS One. 2015;10(10)

  6. Scott Jr RT, Upham KM, Forman EJ, Zhao T, Treff NR. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril. 2013;100:624–30.

    Article  PubMed  Google Scholar 

  7. Fragouli E, Lenzi M, Ross R, Katz-Jaffe M, Schoolcraft WB, Wells D. Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod. 2008;23(11):2596–608.

    Article  CAS  PubMed  Google Scholar 

  8. Johnson DS, Cinnioglu C, Ross R, Filby A, Gemelos G, Hill M, et al. Comprehensive analysis of karyotypic mosaicism between trophectoderm and inner cell mass. Mol Hum Reprod. 2010;12:944–9.

    Article  Google Scholar 

  9. Northrop LE, Treff NR, Levy B, Scott Jr RT. SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts. Mol Hum Reprod. 2010;8:590–600.

    Article  Google Scholar 

  10. Capalbo A, Bono S, Spizzichino L, Biricik A, Baldi M, Colamaria S, et al. Sequential comprehensive chromosome analysis on polar bodies, blastomeres and trophoblast: insights into female meiotic errors and chromosomal segregation in the preimplantation window of embryo development. Hum Reprod. 2013;28:509–18.

    Article  CAS  PubMed  Google Scholar 

  11. Glujovsky D, Blake D, Farquhar C, Bardach A. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev. 2012;7:CD002118.

    PubMed  Google Scholar 

  12. Ubaldi FM, Capalbo A, Colamaria S, Ferrero S, Maggiulli R, Vajta G, et al. Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study. Hum Reprod. 2015;30(9):2097–106.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, et al. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertil Steril. 2013;100(1):100–7.

    Article  PubMed  Google Scholar 

  14. Practice Committee of Society for Assisted Reproductive Technology, Practice Committee of American Society for Reproductive Medicine. Preimplantion genetic testing: a Practice Committee opinion. Fertil Steril. 2008;90(5 Suppl):S136–43.

    Google Scholar 

  15. Wale PL, Gardner DK. The effects of chemical and physical factors on mammalian embryo culture and their importance for the practice of assisted human reproduction. Hum Reprod Update. 2016;22(1):2–22.

    Article  PubMed  Google Scholar 

  16. McArthur SJ, Leigh D, Marshall JT, de Boer KA, Jansen RP. Pregnancies and live births after trophectoderm biopsy and preimplantation genetic testing of human blastocysts. Fertil Steril. 2005;84(6):1628–36.

    Article  PubMed  Google Scholar 

  17. Schoolcraft WB, Fragouli E, Stevens J, Munne S, Katz-Jaffe MG, Wells D. Clinical application of comprehensive chromosomal screening at the blastocyst stage. Fertil Steril. 2010;94(5):1700–6.

    Article  PubMed  Google Scholar 

  18. Capalbo A, Rienzi L, Cimadomo D, Maggiulli R, Elliott T, Wright G, et al. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts. Hum Reprod. 2014;29(6):1173–81.

    Article  PubMed  Google Scholar 

  19. Feichtinger W, Strohmer H, Fuhrberg P, Radivojevic K, et al. Photoablation of oocyte zona pellucida by erbium-YAG laser for in-vitro fertilisation in severe male infertility. Lancet. 1992;339(8796):811.

    Article  CAS  PubMed  Google Scholar 

  20. Cohen J, Alikani M, Garrisi JG, Willadsen S. Micromanipulation of human gametes and embryos: ooplasmic donation at fertilization. Hum Reprod Update. 1998;4(2):195–6.

    Article  CAS  PubMed  Google Scholar 

  21. Cohen J, Malter H, Elsner C, Kort H, et al. Immunosuppression supports implantation of zona pellucida dissected human embryos. Fertil Steril. 1990;53(4):662–5.

    Article  CAS  PubMed  Google Scholar 

  22. Eldar-Geva T, Srebnik N, Altarescu G, Varshaver I, et al. Neonatal outcome after preimplantation genetic diagnosis. Fertil Steril. 2014;102(4):1016–21.

    Article  PubMed  Google Scholar 

  23. De Vos A, Van Steirteghem A. Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat Diagn. 2001;21(9):767–80.

    Article  PubMed  Google Scholar 

  24. Geber S, Bossi R, Lisboa CB, Valle M, et al. Laser confers less embryo exposure than acid tyrode for embryo biopsy in preimplantation genetic diagnosis cycles: a randomized study. Reprod Biol Endocrinol. 2011;9:58.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Rink K, Delacrétaz G, Salathé RP, Senn A, et al. Non-contact microdrilling of mouse zona pellucida with an objective-delivered 1.48-microns diode laser. Lasers Surg Med. 1996;18(1):52–62.

    Article  CAS  PubMed  Google Scholar 

  26. Taylor TH, Gilchrist JW, Hallowell SV, Hanshew KK, et al. The effects of different laser pulse lengths on the embryo biopsy procedure and embryo development to the blastocyst stage. J Assist Reprod Genet. 2010;27(11):663–7.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Capalbo A, Rienzi L, Ubaldi FM. New approaches for multifactor preimplantation genetic diagnosis of monogenic diseases and aneuploidies from a single biopsy. Fertil Steril. 2016;105(2):297–8.

    Article  PubMed  Google Scholar 

  28. Cimadomo D, Capalbo A, Ubaldi FM, Scarica C, Palagiano A, Canipari R, Rienzi L. The impact of biopsy on human embryo developmental potential during preimplantation genetic diagnosis. BioMed Research International 2016.

  29. Rienzi L, Capalbo A, Stoppa M, Romano S, Maggiulli R, Albricci L, et al. No evidence of association between blastocyst aneuploidy and morphokinetic assessment in a selected population of poor-prognosis patients: a longitudinal cohort study. Reprod Biomed Online. 2015;30(1):57–66.

    Article  CAS  PubMed  Google Scholar 

  30. Basile N, Nogales Mdel C, Bronet F, Florensa M, Riqueiros M, Rodrigo L, et al. Increasing the probability of selecting chromosomally normal embryos by time-lapse morphokinetics analysis. Fertil Steril. 2014;101(3):699–704.

    Article  PubMed  Google Scholar 

  31. Campbell A, Fishel S, Bowman N, Duffy S, Sedler M, Thornton S. Retrospective analysis of outcomes after IVF using an aneuploidy risk model derived from time-lapse imaging without PGS. Reprod Biomed Online. 2013;27(2):140–6.

    Article  PubMed  Google Scholar 

  32. Kaser DJ, Racowsky C. Clinical outcomes following selection of human preimplantation embryos with time-lapse monitoring: a systematic review. Hum Reprod Update. 2014;20(5):617–31.

    Article  PubMed  Google Scholar 

  33. Kirkegaard K, Ahlström A, Ingerslev HJ, Hardarson T. Choosing the best embryo by time lapse versus standard morphology. Fertil Steril. 2015;103(2):323–32.

    Article  PubMed  Google Scholar 

  34. Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw MA. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet. 2010;47:651–8.

    Article  PubMed  Google Scholar 

  35. Rechitsky S, Pakhalchuk T, San Ramos G, Goodman A, Zlatopolsky Z, Kuliev A. First systematic experience of preimplantation genetic diagnosis for single-gene disorders, and/or preimplantation human leukocyte antigen typing, combined with 24-chromosome aneuploidy testing. Fertil Steril. 2015;103(2):503–12.

    Article  PubMed  Google Scholar 

  36. Zimmerman RS, Jalas C, Tao X, Fedick AM, Kim JG, Pepe RJ, et al. Development and validation of concurrent preimplantation genetic diagnosis for single gene disorders and comprehensive chromosomal aneuploidy screening without whole genome amplification. Fertil Steril. 2016;105(2):286–94.

    Article  CAS  PubMed  Google Scholar 

  37. Treff NR, Levy B, Su J, Northrop LE, Tao X, Scott Jr RT. SNP microarray-based 24 chromosome aneuploidy screening is significantly more consistent than FISH. Mol Hum Reprod. 2010;16:583–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Treff NR, Scott Jr RT. Four-hour quantitative real-time polymerase chain reaction-based comprehensive chromosome screening and accumulating evidence of accuracy, safety, predictive value, and clinical efficacy. Fertil Steril. 2013;99:1049–53.

    Article  CAS  PubMed  Google Scholar 

  39. Capalbo A, Treff NR, Cimadomo D, Tao X, Upham K, Ubaldi FM, et al. Comparison of array comparative genomic hybridization and quantitative real-time PCR-based aneuploidy screening of blastocyst biopsies. Eur J Hum Genet. 2015;23(7):901–6.

    Article  CAS  PubMed  Google Scholar 

  40. Scott Jr RT, Upham KM, Forman EJ, Hong KH, Scott KL, Taylor D, et al. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril. 2013;100(3):697–703.

    Article  PubMed  Google Scholar 

  41. Treff NR, Tao X, Ferry KM, Su J, Taylor D, Scott Jr RT. Development and validation of an accurate quantitative real-time polymerase chain reaction-based assay for human blastocyst comprehensive chromosomal aneuploidy screening. Fertil Steril. 2012;97(4):819–24.

    Article  CAS  PubMed  Google Scholar 

  42. Capalbo A, Ubaldi FM, Cimadomo D, Maggiulli R, Patassini C, Dusi L, et al. Consistent and reproducible outcomes of blastocyst biopsy and aneuploidy screening across different biopsy practitioners: a multicentre study involving 2586 embryo biopsies. Hum Reprod. 2016;31(1):199–208.

    Article  PubMed  Google Scholar 

  43. Treff NR, Fedick A, Tao X, Devkota B, Taylor D, Scott Jr RT. Evaluation of targeted next-generation sequencing-based preimplantation genetic diagnosis of monogenic disease. Fertil Steril. 2013;99:1377–84.

    Article  CAS  PubMed  Google Scholar 

  44. Werner MD, Franasiak JM, Hong KH, Juneau CR, Tao X, Landis J, Upham KM, Treff NR, Scott RT. A prospective, blinded, non-selection study to determine the predictive value of ploidy results using a novel method of targeted amplification based next generation sequencing (NGS) for comprehensive chromosome screening (CCS). ASRM abstract book 2015.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Capalbo.

Additional information

Future efforts will focus on clinical validation of novel CCS methods based on approaches replacing the use of WGA with targeted next-generation sequencing technology, to improve the throughput of analysis and the overall cost effectiveness of PGD/PGD-A.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Capalbo, A., Romanelli, V., Cimadomo, D. et al. Implementing PGD/PGD-A in IVF clinics: considerations for the best laboratory approach and management. J Assist Reprod Genet 33, 1279–1286 (2016). https://doi.org/10.1007/s10815-016-0768-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-016-0768-3

Keywords

Navigation